Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Adenocarcinoma × Carboplatin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 11 OTHER 5 UNKNOWN 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

pembrolizumab 1 Pemetrexed 1 Paclitaxel 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

ChineseAMS

Phase 1/2 Unknown

Adenocarcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡